ACE inhibitors in renal disease

Endothelin inhibition as a biologic target for treating hypertension.

American journal of hypertension·1998

Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells.

Arteriosclerosis, thrombosis, and vascular biology·1998

Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.

Journal of hypertension·1998

Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.

Journal of cardiovascular pharmacology·1998

Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients.

Journal of hypertension·1998

Age-related changes of the mechanical properties of the carotid artery in spontaneously hypertensive rats.

Journal of hypertension·1998

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026

Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?

Kidney international·2026

What does it mean to win? Interpreting hierarchical kidney outcomes in hypertension trials.

Kidney international·2026

Resolving the VEGF paradox in DKD: VEGFR1 blockade shows promising renoprotection.

Kidney international·2026

Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus Penicillium herquei.

Journal of Asian natural products research·2026

In Vitro Effects of Centaurea ovina (Roudbari Cornflower) Aqueous and Ethanolic Extracts on Staphylococcus saprophyticus: Growth Inhibition, Antibiofilm Activity, and Reduced ureC/uafA Transcripts.

International journal of microbiology·2026

Sperm-disrupting activity of a root bark fraction of Flueggea virosa (Roxb. ex willd.) royle uncovered using LC-MS/MS profiling and functional evaluation.

Frontiers in pharmacology·2026

The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.

Frontiers in behavioral neuroscience·2026

Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?

Expert opinion on pharmacotherapy·2026

Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.

Endocrine, metabolic & immune disorders drug targets·2026

Related Experiment Videos

ACE inhibitors in renal disease

Related Concept Videos

Endothelin inhibition as a biologic target for treating hypertension.

Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells.

Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.

Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.

Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients.

Age-related changes of the mechanical properties of the carotid artery in spontaneously hypertensive rats.

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Asymptomatic serologic reactivation in patients with lupus nephritis in clinical remission: to treat or not to treat?

What does it mean to win? Interpreting hierarchical kidney outcomes in hypertension trials.

Resolving the VEGF paradox in DKD: VEGFR1 blockade shows promising renoprotection.

Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus <i>Penicillium herquei</i>.

In Vitro Effects of <i>Centaurea ovina</i> (Roudbari Cornflower) Aqueous and Ethanolic Extracts on <i>Staphylococcus saprophyticus</i>: Growth Inhibition, Antibiofilm Activity, and Reduced <i>ureC</i>/<i>uafA</i> Transcripts.

Sperm-disrupting activity of a root bark fraction of <i>Flueggea virosa</i> (Roxb. ex willd.) royle uncovered using LC-MS/MS profiling and functional evaluation.

The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.

Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?

Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.

Related Experiment Videos

ACE inhibitors in renal disease

Related Concept Videos

Related Articles